Pharmaceutical group · Spain
FAES
A group of 13 companies with 100 medicines in 3 countries.
Group structure
13 companies in 3 countries
Loading…
Pharmaceutical group · Spain
A group of 13 companies with 100 medicines in 3 countries.
13 companies in 3 countries
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine of every company in the group, current ones first.
1–25 of 100
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACTIMAG 400 MG/ML SOLUCION ORAL40 g · Solución oral | Pidolate | Spain | Marketed | 1984 |
| ALERGICAL 0,5 mg/ 0,1mg/g CREMA0,1 mg + 0,5 mg · Crema | Fluocinolone acetonide, Betamethasone | Spain | Marketed | 1973 |
| ANALGILASA 500 mg /30 mg/ 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA500 mg + 30 mg + 10 mg · Comprimido recubierto con película | Paracetamol, Caffeine, Codeine | Spain | Marketed | 1969 |
| ANALGIPLUS 500 mg/30 mg COMPRIMIDOS RECUBIERTOS CON PELICULA500 mg + 30 mg · Comprimido recubierto con película | Paracetamol, Codeine | Spain | Marketed | 2000 |
| ASTRILAX 20 MG COMPRIMIDOS20 mg · Comprimido | Bilastine | Spain | Marketed | 2025 |
| ASTRILAX FLAS 20 MG COMPRIMIDOS BUCODISPERSABLES20 mg · Comprimido bucodispersable | Bilastine | Spain | Marketed | 2025 |
| AZZAVIX 1000 MG COMPRIMIDOS GASTRORRESISTENTES1000 mg · Comprimido gastrorresistente | Mesalazine | Spain | Authorised | 2021 |
| AZZAVIX 1500 MG COMPRIMIDOS GASTRORRESISTENTES1500 mg · Comprimido gastrorresistente | Mesalazine | Spain | Authorised | 2026 |
| AZZAVIX 500 MG COMPRIMIDOS GASTRORRESISTENTES500 mg · Comprimido gastrorresistente | Mesalazine | Spain | Authorised | 2020 |
| BILAXTEN 12 MG/ML SOLUCIÓN INYECTABLE12 mg/ml · Solución inyectable | Bilastine | Spain | Authorised | 2025 |
| BILAXTEN 2,5 MG/ML SOLUCION ORAL2,5 mg · Solución oral | Bilastine | Spain | Marketed | 2017 |
| BILAXTEN 20 mg COMPRIMIDOS20 mg · Comprimido | Bilastine | Spain | Marketed | 2010 |
| BILAXTEN 6 MG/ML COLIRIO EN SOLUCION6 mg/ml · Colirio en solución | Bilastine | Spain | Marketed | 2022 |
| BILAXTEN FLAS 10 MG COMPRIMIDOS BUCODISPERSABLES10 mg · Comprimido bucodispersable | Bilastine | Spain | Marketed | 2017 |
| BILAXTEN FLAS 20 MG COMPRIMIDOS BUCODISPERSABLES20 mg · Comprimido bucodispersable | Bilastine | Spain | Marketed | 2023 |
| BLENIX 1.000 MG COMPRIMIDOS GASTRORRESISTENTES500 mg · Comprimido gastrorresistente | Mesalazine | Spain | Authorised | 2023 |
| BLENIX 1500 MG COMPRIMIDOS GASTRORRESISTENTES1500 mg · Comprimido gastrorresistente | Mesalazine | Spain | Authorised | 2026 |
| BLENIX 500 MG COMPRIMIDOS GASTRORRESISTENTES500 mg · Comprimido gastrorresistente | Mesalazine | Spain | Authorised | 2023 |
| BRONQUIDIAZINA CR SUSPENSIÓN ORAL400 mg + 4 mg + 80 mg + 32,5 mg · Suspensión oral | Sulfamethoxazole, Bromhexine, Trimethoprim, Balsamo tolu exto fluido | Spain | Marketed | 1977 |
| CITICOLINA FAES 1000 MG SOLUCION ORAL EFG1045 mg · Solución oral | Citicolina | Spain | Marketed | 2018 |
| CLAVERSAL 1 G COMPRIMIDOS GASTRORRESISTENTES1000 mg · Comprimido gastrorresistente | Mesalazine | Spain | Marketed | 2018 |
| CLAVERSAL 500 mg COMPRIMIDOS GASTRORRESISTENTES500 mg · Comprimido gastrorresistente | Mesalazine | Spain | Marketed | 1988 |
| CLAVERSAL 500 mg SUPOSITORIOS500 mg · Supositorio | Mesalazine | Spain | Marketed | 1995 |
| CLAVERSAL ESPUMA RECTAL1,066 g · Espuma rectal | Mesalazine | Spain | Marketed | 1997 |
| Dediol wekelijks 72 microgram zachte capsulesCapsule, zacht | Calcifediol | Netherlands | Authorised | 2024 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 96 | 83 | 13 | CompaniesAll medicines |
| Netherlands | 3 | 3 | 0 | CompaniesAll medicines |
| Colombia | 1 | 0 | 1 | CompaniesAll medicines |
Also in the registers of Brazil, Croatia, Italy, Malaysia, Singapore, Sweden, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
Report an error or request removalCorrections from the company itself are welcome.
Keep FAES’s medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callCollege ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Läkemedelsverket, Sweden, Förvaringstemperatur och hållbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Läkemedelsverket, Sweden, Läkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Well-known pharmaceutical groups, each with all its companies.
Ranked by their number of medicines.